Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.

Mühlbacher M, Konstantinidis A, Kasper S, Eichberger G, Hinterhuber H, Hofmann P, Nimmerrichter A, Schubert H, Egger C, Nickel M, Stuppaeck C.

Neuropsychobiology. 2006;53(2):83-7. Epub 2006 Feb 23.

PMID:
16511339
2.

Intravenous mirtazapine in the treatment of depressed inpatients.

Konstantinidis A, Stastny J, Ptak-Butta J, Hilger E, Winkler D, Barnas C, Neumeister A, Kasper S.

Eur Neuropsychopharmacol. 2002 Feb;12(1):57-60.

PMID:
11788241
3.

A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.

Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.

Int Clin Psychopharmacol. 2003 May;18(3):133-41.

PMID:
12702891
4.
5.

Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.

Schüle C, Baghai TC, Eser D, Hecht S, Hermisson I, Born C, Häfner S, Nothdurfter C, Rupprecht R.

World J Biol Psychiatry. 2007;8(2):112-22.

PMID:
17455104
6.

Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.

Kim JE, Yoon SJ, Kim J, Jung JY, Jeong HS, Cho HB, Shin E, Lyoo IK, Kim TS.

Int J Clin Pract. 2011 Mar;65(3):323-9. doi: 10.1111/j.1742-1241.2010.02624.x.

PMID:
21314870
7.

Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.

Schüle C, Baghai TC, Eser D, Nothdurfter C, Rupprecht R.

World J Biol Psychiatry. 2009;10(4 Pt 2):390-9. doi: 10.1080/15622970701849978.

PMID:
18609420
8.
9.
10.

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.

Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH.

Int Clin Psychopharmacol. 2010 Jul;25(4):189-98. doi: 10.1097/YIC.0b013e328330adb2.

PMID:
20531012
11.

Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA; OPERATION Study Team.

J Clin Psychopharmacol. 2010 Aug;30(4):357-64. doi: 10.1097/JCP.0b013e3181e7784f.

PMID:
20571433
12.

Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.

Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M.

J Clin Pharm Ther. 2005 Apr;30(2):133-8.

PMID:
15811165
13.

Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.

Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.

J Clin Psychopharmacol. 2003 Aug;23(4):358-64. Erratum in: J Clin Psychopharmacol. 2003 Dec;23(6):682.

PMID:
12920411
14.

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.

Kasper S.

Int Clin Psychopharmacol. 1995 Dec;10 Suppl 4:25-35. Review. Erratum in: Int Clin Psychopharmacol 1996 Jun;11(2):153.

PMID:
8930007
15.

Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.

Haapasalo-Pesu KM, Vuola T, Lahelma L, Marttunen M.

J Child Adolesc Psychopharmacol. 2004 Summer;14(2):175-84.

PMID:
15319015
16.

Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.

Danileviciūte V, Sveikata A, Adomaitiene V, Gumbrevicius G, Fokas V, Sveikatiene R.

Medicina (Kaunas). 2009;45(10):778-84.

17.

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.

Malhi GS, Ng F, Berk M.

Aust N Z J Psychiatry. 2008 Apr;42(4):346-9. doi: 10.1080/00048670701881587.

PMID:
18330778
18.

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH.

Am J Psychiatry. 2006 Jul;163(7):1161-72.

PMID:
16816220
19.

The effect of mirtazapine in patients with chronic pain and concomitant depression.

Freynhagen R, Muth-Selbach U, Lipfert P, Stevens MF, Zacharowski K, Tölle TR, von Giesen HJ.

Curr Med Res Opin. 2006 Feb;22(2):257-64.

PMID:
16466597
20.

Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.

Saiz-Ruiz J, Montes JM, Ibáñez A, Díaz M, Vicente F, Pelegrín C, Viñas R, Arias F, Carrasco JL, Ferrando L.

Hum Psychopharmacol. 2005 Aug;20(6):435-40.

PMID:
16106478

Supplemental Content

Support Center